Percutaneous-transluminal vascular intervention on heart and coronary vessels: Measures for embolism protection on the left heart ear: Implantation of a permanent embolism protection system Transseptal left heart catheter examination: pressure measurement Transesophageal Echocardiography [TEE] I48 I63
Conditions
Interventions
Group 1: The time schedule for a study patient is as follows:
If the atrial oocluder is indicated, the patient will be informed about this procedure. Within the scope of this, we offer the possibility
Sponsors
Klinikum Friedrichshafen GmbH Klinik für Kardiologie, Angiologie, Pneumologie und Internistische Intensivmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: >18 years written, informed consent signed transfer agreement for tissue samples
Exclusion criteria
Exclusion criteria: Age <18 years no indication for LAA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| How often in patients with an LAA is material used in the both filters of the dual filter protection system? Which material (thrombus, myocardium, calcium, foreign body) is found in these filters? | — |
Secondary
| Measure | Time frame |
|---|---|
| What is the number and size of the collected particles? Is there an association between device size selection or procedural data (periprocedural blood dilution, blood pressure) in relation to the number and Scope of the collected material? | — |
Countries
Germany
Contacts
Public ContactNils Freier
Klinikum Friedrichshafen GmbH
Outcome results
None listed